Get started
Author

Roberta Pica

Observed names: Pica Roberta, Pica, Roberta, R PICA, R Pica, R. PICA, R. Pica
Observed institutions: University of Rome Tor Vergata, Yonsei University, Istituto Superiore di Sanità, Azienda Ospedaliera San Giovanni Addolorata, Policlinico Umberto I, University of Oxford, ASL Roma, Federico II University Hospital, Ospedale Sandro Pertini, Sapienza University of Rome
ORCID: 0000-0002-1097-9430
Observed ORCID: 0000-0002-1097-9430
OpenAlex ID: A5008050913
Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease
2015 · Giovanni Monteleone, Markus F. Neurath, et al. · New England Journal of Medicine · 408
PDF
Azathioprine or methotrexate in the treatment of patients with steroid‐dependent or steroid‐resistant ulcerative colitis: results of an open‐label study on efficacy and tolerability in inducing and maintaining remission
2002 · O. A. Paoluzi, R. Pica, et al. · Alimentary Pharmacology & Therapeutics · 135
PDF
Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis.
1996 · M Boirivant, R Pica, et al. · Journal of Clinical Investigation · 135
PDF
Inter-observer agreement in endoscopic scoring systems: Preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD)
2014 · Marco Daperno, Michele Comberlato, et al. · Digestive and Liver Disease · 122
Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects
2001 · M.C. Di Paolo, O.A. Paoluzi, et al. · Digestive and Liver Disease · 86
Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1‐year follow‐up study
2005 · O. A. Paoluzi, F. Iacopini, et al. · Alimentary Pharmacology & Therapeutics · 85
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study
2021 · Severine Vermeire, Peter L Lakatos, et al. · The Lancet. Gastroenterology & hepatology · 78
PDF
2‐Week Triple Therapy for Helicobacter pylori Infection is Better Than 1‐Week in Clinical Practice: a Large Prospective Single‐Center Randomized Study
2006 · Paolo Paoluzi, Federico Iacopini, et al. · Helicobacter · 75
Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence
2004 · Marco Di Tola, Luigi Sabbatella, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 72
Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community Gastroenterologists
2016 · Marco Daperno, Michele Comberlato, et al. · Journal of Crohn s and Colitis · 64
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
2017 · Livia Biancone, Vito Annese, et al. · Digestive and Liver Disease · 60
PDF
Anti-CXCL4 Antibody Reactivity Is Present in Systemic Sclerosis (SSc) and Correlates with the SSc Type I Interferon Signature
2020 · Roberto Lande, Anna Mennella, et al. · International Journal of Molecular Sciences · 56
PDF
Oral Mesalazine (5-ASA) Treatment May Protect Against Proximal Extension of Mucosal Inflammation in Ulcerative Proctitis
2004 · Roberta Pica, Omero Alessandro Paoluzi, et al. · Inflammatory Bowel Diseases · 53
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients
2021 · Antonio Tursi, Giammarco Mocci, et al. · European Journal of Gastroenterology & Hepatology · 44
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
2019 · Gionata Fiorino, Flavio Caprioli, et al. · Digestive and Liver Disease · 43
PDF
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease
2022 · Laurent Peyrin-Biroulet, Jean-François Rahier, et al. · Clinical Gastroenterology and Hepatology · 42
PDF
IL-13 mRNA Tissue Content Identifies Two Subsets of Adult Ulcerative Colitis Patients With Different Clinical and Mucosa-Associated Microbiota Profiles
2019 · Alessia Butera, Monica Di Paola, et al. · Journal of Crohn s and Colitis · 42
PDF
Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus
2020 · R. Lande, R. Palazzo, et al. · Scientific Reports · 41
PDF
Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial
2002 · P. Paoluzi, G. D'Albasio, et al. · Digestive and Liver Disease · 39
Diffuse febrile dermatosis in a patient with active ulcerative colitis under treatment with steroids and azathioprine: a case of Sweet’s syndrome
2004 · O.A. Paoluzi, P. Crispino, et al. · Digestive and Liver Disease · 34
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study
2022 · Antonio Tursi, Giammarco Mocci, et al. · Inflammatory Bowel Diseases · 33
A randomized trial comparing 4.8 vs. 2.4g/day of oral mesalazine for maintenance of remission in ulcerative colitis
2015 · Roberta Pica, Claudio Cassieri, et al. · Digestive and Liver Disease · 31
Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: An IG-IBD study
2010 · Perla Bertomoro, Sara Renna, et al. · Journal of Crohn s and Colitis · 31
One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication
2005 · F. Iacopini, P. Crispino, et al. · Digestive and Liver Disease · 31
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases
2020 · Devis Benfaremo, Michele Maria Luchetti, et al. · The Journal of Rheumatology · 28
Works count: 170
Citation count: 2,432
H-index: 26
I10-index: 49
Year
Topic
Type